HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.

Abstract
Thyroid cancer incidence is rapidly increasing. Papillary Thyroid Carcinoma (PTC), the most frequent hystotype, usually displays good prognosis, but no effective therapeutic options are available for the fraction of progressive PTC patients. BRAF and RET/PTC are the most frequent driving genetic lesions identified in PTC. We developed two complementary in vitro models based on RET/PTC1 oncogene, starting from the hypothesis that miRNAs modulated by a driving PTC-oncogene are likely to have a role in thyroid neoplastic processes. Through this strategy, we identified a panel of deregulated miRNAs. Among these we focused on miR-199a-3p and showed its under-expression in PTC specimens and cell lines. We demonstrated that miR-199a-3p restoration in PTC cells reduces MET and mTOR protein levels, impairs migration and proliferation and, more interesting, induces lethality through an unusual form of cell death similar to methuosis, caused by macropinocytosis dysregulation. Silencing MET or mTOR, both involved in survival pathways, does not recapitulate miR-199a-3p-induced cell lethality, thus suggesting that the cooperative regulation of multiple gene targets is necessary. Integrated analysis of miR-199a-3p targets unveils interesting networks including HGF and macropinocytosis pathways. Overall our results indicate miR-199a-3p as a tumor suppressor miRNA in PTC.
AuthorsEmanuela Minna, Paola Romeo, Loris De Cecco, Matteo Dugo, Giuliana Cassinelli, Silvana Pilotti, Debora Degl'Innocenti, Cinzia Lanzi, Patrizia Casalini, Marco A Pierotti, Angela Greco, Maria Grazia Borrello
JournalOncotarget (Oncotarget) Vol. 5 Issue 9 Pg. 2513-28 (May 15 2014) ISSN: 1949-2553 [Electronic] United States
PMID24810336 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MicroRNAs
  • RNA, Messenger
  • mirn199 microRNA, human
  • MTOR protein, human
  • MET protein, human
  • Proto-Oncogene Proteins c-met
  • TOR Serine-Threonine Kinases
Topics
  • Apoptosis
  • Blotting, Western
  • Carcinoma, Papillary (genetics, metabolism, pathology)
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Fluorescent Antibody Technique
  • Genes, Tumor Suppressor
  • Humans
  • Immunoenzyme Techniques
  • MicroRNAs (genetics)
  • Pinocytosis
  • Proto-Oncogene Proteins c-met (genetics, metabolism)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • TOR Serine-Threonine Kinases (genetics, metabolism)
  • Thyroid Gland (metabolism)
  • Thyroid Neoplasms (genetics, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: